 James Costello
Concepts (422)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder Neoplasms | 12 | 2024 | 228 | 2.890 |
Why?
| | Cisplatin | 4 | 2024 | 300 | 1.620 |
Why?
| | Drug Resistance, Neoplasm | 8 | 2024 | 759 | 1.570 |
Why?
| | Computational Biology | 10 | 2025 | 599 | 1.540 |
Why?
| | Gene Expression Profiling | 10 | 2024 | 1706 | 1.370 |
Why?
| | Down Syndrome | 4 | 2025 | 481 | 1.300 |
Why?
| | Algorithms | 13 | 2018 | 1622 | 1.240 |
Why?
| | Antineoplastic Agents | 9 | 2024 | 2061 | 1.150 |
Why?
| | Cell Line, Tumor | 21 | 2025 | 3215 | 1.000 |
Why?
| | Transcriptome | 8 | 2024 | 887 | 0.880 |
Why?
| | Biomarkers, Tumor | 5 | 2022 | 1181 | 0.860 |
Why?
| | Gene Regulatory Networks | 6 | 2023 | 284 | 0.850 |
Why?
| | Neoplasms | 9 | 2024 | 2470 | 0.770 |
Why?
| | Prostatic Neoplasms | 4 | 2023 | 1016 | 0.760 |
Why?
| | Crowdsourcing | 5 | 2023 | 18 | 0.760 |
Why?
| | Computer Simulation | 5 | 2018 | 943 | 0.750 |
Why?
| | Premature Birth | 2 | 2023 | 314 | 0.730 |
Why?
| | Cell-Free Nucleic Acids | 1 | 2021 | 31 | 0.710 |
Why?
| | Gene Expression Regulation, Neoplastic | 15 | 2025 | 1356 | 0.710 |
Why?
| | Blood Proteins | 1 | 2021 | 242 | 0.640 |
Why?
| | Pre-Eclampsia | 1 | 2021 | 186 | 0.620 |
Why?
| | MutS Homolog 2 Protein | 1 | 2018 | 14 | 0.620 |
Why?
| | Chromosomes, Human | 1 | 2018 | 41 | 0.610 |
Why?
| | Pharmaceutical Preparations | 1 | 2020 | 171 | 0.600 |
Why?
| | Fluorescence | 1 | 2018 | 160 | 0.580 |
Why?
| | Gestational Age | 1 | 2021 | 874 | 0.580 |
Why?
| | Whole Genome Sequencing | 1 | 2018 | 130 | 0.570 |
Why?
| | Tripartite Motif Proteins | 1 | 2017 | 29 | 0.570 |
Why?
| | Transcription Factors | 4 | 2022 | 1651 | 0.570 |
Why?
| | CRISPR-Cas Systems | 1 | 2018 | 109 | 0.560 |
Why?
| | Models, Biological | 4 | 2018 | 1722 | 0.560 |
Why?
| | Metabolic Networks and Pathways | 1 | 2018 | 178 | 0.550 |
Why?
| | Genetic Loci | 1 | 2018 | 275 | 0.540 |
Why?
| | Homeodomain Proteins | 5 | 2023 | 495 | 0.520 |
Why?
| | Breast Neoplasms | 5 | 2021 | 2142 | 0.520 |
Why?
| | Body Mass Index | 1 | 2025 | 2273 | 0.520 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2017 | 153 | 0.510 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 5 | 2023 | 1565 | 0.500 |
Why?
| | Genomics | 6 | 2023 | 716 | 0.470 |
Why?
| | Telomerase | 4 | 2020 | 233 | 0.460 |
Why?
| | MAP Kinase Kinase Kinases | 3 | 2021 | 71 | 0.450 |
Why?
| | Humans | 62 | 2025 | 129650 | 0.440 |
Why?
| | Triple Negative Breast Neoplasms | 3 | 2025 | 197 | 0.440 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 744 | 0.440 |
Why?
| | Competitive Behavior | 1 | 2013 | 41 | 0.410 |
Why?
| | Oligonucleotide Array Sequence Analysis | 7 | 2016 | 769 | 0.390 |
Why?
| | Chromosomes, Human, Pair 21 | 2 | 2025 | 43 | 0.390 |
Why?
| | DNA-Binding Proteins | 6 | 2022 | 1443 | 0.390 |
Why?
| | Receptors, Androgen | 3 | 2021 | 147 | 0.380 |
Why?
| | Obesity | 1 | 2025 | 2883 | 0.370 |
Why?
| | Carcinoma, Transitional Cell | 3 | 2017 | 60 | 0.360 |
Why?
| | Cooperative Behavior | 2 | 2016 | 433 | 0.360 |
Why?
| | Biomedical Research | 2 | 2016 | 638 | 0.350 |
Why?
| | Drosophila | 3 | 2008 | 143 | 0.340 |
Why?
| | Rhabdomyosarcoma | 2 | 2022 | 64 | 0.340 |
Why?
| | Cadherins | 3 | 2024 | 188 | 0.330 |
Why?
| | Lung Neoplasms | 3 | 2018 | 2344 | 0.330 |
Why?
| | Mutation | 7 | 2023 | 3717 | 0.320 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2023 | 270 | 0.320 |
Why?
| | Zebrafish Proteins | 2 | 2022 | 265 | 0.310 |
Why?
| | Protein Interaction Mapping | 1 | 2009 | 108 | 0.310 |
Why?
| | Animals | 30 | 2025 | 35361 | 0.310 |
Why?
| | Neoplasm Metastasis | 6 | 2025 | 610 | 0.290 |
Why?
| | Protein Tyrosine Phosphatases | 2 | 2020 | 168 | 0.290 |
Why?
| | Aminopeptidases | 2 | 2024 | 17 | 0.280 |
Why?
| | Xenograft Model Antitumor Assays | 4 | 2024 | 814 | 0.280 |
Why?
| | Drosophila melanogaster | 1 | 2009 | 215 | 0.280 |
Why?
| | Databases, Genetic | 3 | 2018 | 232 | 0.280 |
Why?
| | Mice | 19 | 2025 | 16937 | 0.270 |
Why?
| | DNA Helicases | 2 | 2021 | 149 | 0.270 |
Why?
| | Prostatic Neoplasms, Castration-Resistant | 2 | 2017 | 44 | 0.270 |
Why?
| | Signal Transduction | 8 | 2025 | 4925 | 0.250 |
Why?
| | Promoter Regions, Genetic | 6 | 2021 | 1207 | 0.240 |
Why?
| | Oncogene Proteins, Fusion | 3 | 2023 | 201 | 0.240 |
Why?
| | Chemokine CCL2 | 1 | 2025 | 118 | 0.230 |
Why?
| | Meta-Analysis as Topic | 2 | 2023 | 170 | 0.230 |
Why?
| | Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2025 | 40 | 0.230 |
Why?
| | Epigenesis, Genetic | 3 | 2020 | 613 | 0.230 |
Why?
| | Pancreatic Neoplasms | 2 | 2023 | 882 | 0.230 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2021 | 202 | 0.230 |
Why?
| | ACTH-Secreting Pituitary Adenoma | 1 | 2024 | 11 | 0.230 |
Why?
| | Cholangiocarcinoma | 1 | 2024 | 77 | 0.210 |
Why?
| | Bile Duct Neoplasms | 1 | 2024 | 99 | 0.210 |
Why?
| | Organoids | 1 | 2024 | 104 | 0.210 |
Why?
| | Neuroendocrine Tumors | 1 | 2024 | 99 | 0.210 |
Why?
| | Datasets as Topic | 1 | 2023 | 110 | 0.200 |
Why?
| | Proteomics | 3 | 2021 | 1062 | 0.200 |
Why?
| | Nuclear Proteins | 2 | 2020 | 663 | 0.200 |
Why?
| | Female | 22 | 2025 | 68776 | 0.200 |
Why?
| | MDS1 and EVI1 Complex Locus Protein | 1 | 2022 | 6 | 0.190 |
Why?
| | Sarcoma, Ewing | 1 | 2023 | 89 | 0.190 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 427 | 0.190 |
Why?
| | Interleukin-13 Receptor alpha2 Subunit | 1 | 2021 | 5 | 0.190 |
Why?
| | Melanoma | 2 | 2023 | 730 | 0.190 |
Why?
| | Neoplasm Invasiveness | 3 | 2018 | 485 | 0.190 |
Why?
| | ROC Curve | 2 | 2021 | 503 | 0.190 |
Why?
| | Muscle Development | 1 | 2022 | 103 | 0.180 |
Why?
| | NF-kappa B | 1 | 2025 | 653 | 0.180 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2023 | 212 | 0.180 |
Why?
| | Cell Proliferation | 8 | 2021 | 2391 | 0.180 |
Why?
| | ADAM10 Protein | 1 | 2021 | 30 | 0.180 |
Why?
| | Asymptomatic Diseases | 1 | 2021 | 84 | 0.180 |
Why?
| | Carcinoma, Lobular | 1 | 2021 | 48 | 0.180 |
Why?
| | Receptors, CCR2 | 1 | 2020 | 39 | 0.180 |
Why?
| | Gamma Rays | 1 | 2021 | 54 | 0.180 |
Why?
| | Gene Ontology | 1 | 2020 | 51 | 0.170 |
Why?
| | PAX3 Transcription Factor | 1 | 2020 | 11 | 0.170 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 1 | 2020 | 19 | 0.170 |
Why?
| | Radiosurgery | 1 | 2023 | 321 | 0.170 |
Why?
| | Forkhead Box Protein O1 | 1 | 2020 | 21 | 0.170 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2021 | 80 | 0.170 |
Why?
| | Cytoreduction Surgical Procedures | 1 | 2020 | 61 | 0.170 |
Why?
| | Wnt Signaling Pathway | 1 | 2022 | 170 | 0.170 |
Why?
| | Neoplasm Recurrence, Local | 3 | 2023 | 964 | 0.170 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 60 | 0.170 |
Why?
| | Radiation Injuries | 1 | 2021 | 135 | 0.160 |
Why?
| | Tumor Microenvironment | 2 | 2020 | 634 | 0.160 |
Why?
| | Receptors, Interferon | 1 | 2019 | 50 | 0.160 |
Why?
| | Homologous Recombination | 1 | 2019 | 23 | 0.160 |
Why?
| | Small Molecule Libraries | 1 | 2020 | 86 | 0.160 |
Why?
| | RNA Interference | 1 | 2021 | 448 | 0.160 |
Why?
| | Discoidin Domain Receptor 2 | 1 | 2019 | 4 | 0.160 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2020 | 381 | 0.160 |
Why?
| | Cell Differentiation | 3 | 2022 | 1902 | 0.160 |
Why?
| | Cytokines | 2 | 2024 | 2017 | 0.150 |
Why?
| | Trisomy | 1 | 2019 | 77 | 0.150 |
Why?
| | CD8-Positive T-Lymphocytes | 3 | 2020 | 857 | 0.150 |
Why?
| | Dasatinib | 1 | 2019 | 54 | 0.150 |
Why?
| | Kynurenine | 1 | 2019 | 114 | 0.150 |
Why?
| | Prognosis | 7 | 2021 | 3794 | 0.150 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3083 | 0.150 |
Why?
| | Chloroquine | 1 | 2018 | 52 | 0.150 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 57 | 0.150 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 399 | 0.150 |
Why?
| | Neoplasm Proteins | 2 | 2018 | 424 | 0.150 |
Why?
| | Receptors, Estrogen | 1 | 2021 | 426 | 0.150 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 131 | 0.150 |
Why?
| | Molecular Conformation | 1 | 2018 | 144 | 0.150 |
Why?
| | Fibrosis | 1 | 2021 | 520 | 0.150 |
Why?
| | Microbiota | 2 | 2023 | 730 | 0.150 |
Why?
| | Neoplasms, Experimental | 1 | 2019 | 171 | 0.150 |
Why?
| | Macrolides | 1 | 2018 | 63 | 0.150 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2020 | 215 | 0.150 |
Why?
| | Monte Carlo Method | 1 | 2018 | 143 | 0.140 |
Why?
| | Neoadjuvant Therapy | 1 | 2020 | 383 | 0.140 |
Why?
| | Lysosomes | 1 | 2018 | 138 | 0.140 |
Why?
| | Histone Code | 1 | 2017 | 31 | 0.140 |
Why?
| | Probability | 1 | 2018 | 306 | 0.140 |
Why?
| | Machine Learning | 2 | 2022 | 443 | 0.140 |
Why?
| | Cell Cycle Proteins | 1 | 2021 | 586 | 0.140 |
Why?
| | Immunity, Cellular | 1 | 2019 | 265 | 0.140 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2020 | 442 | 0.140 |
Why?
| | Cell Death | 1 | 2018 | 354 | 0.140 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 232 | 0.130 |
Why?
| | Data Interpretation, Statistical | 2 | 2009 | 335 | 0.130 |
Why?
| | DNA Damage | 1 | 2019 | 384 | 0.130 |
Why?
| | Adenocarcinoma | 1 | 2023 | 898 | 0.130 |
Why?
| | Histidine Kinase | 1 | 2016 | 34 | 0.130 |
Why?
| | CD24 Antigen | 1 | 2016 | 20 | 0.130 |
Why?
| | YY1 Transcription Factor | 1 | 2016 | 28 | 0.130 |
Why?
| | Nomograms | 1 | 2016 | 47 | 0.130 |
Why?
| | Urologic Neoplasms | 1 | 2016 | 26 | 0.130 |
Why?
| | Transcriptional Activation | 1 | 2018 | 366 | 0.130 |
Why?
| | B7-H1 Antigen | 1 | 2018 | 196 | 0.130 |
Why?
| | Sulfonamides | 1 | 2020 | 496 | 0.130 |
Why?
| | Organizational Innovation | 2 | 2016 | 139 | 0.130 |
Why?
| | Drug Delivery Systems | 1 | 2019 | 336 | 0.120 |
Why?
| | Deoxycytidine | 1 | 2017 | 165 | 0.120 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 161 | 0.120 |
Why?
| | DNA Methylation | 2 | 2017 | 607 | 0.120 |
Why?
| | Genetic Heterogeneity | 1 | 2015 | 58 | 0.120 |
Why?
| | rho Guanine Nucleotide Dissociation Inhibitor beta | 1 | 2014 | 4 | 0.120 |
Why?
| | Bayes Theorem | 3 | 2023 | 375 | 0.120 |
Why?
| | Up-Regulation | 1 | 2018 | 840 | 0.120 |
Why?
| | Telomere Homeostasis | 1 | 2015 | 29 | 0.120 |
Why?
| | Ovarian Neoplasms | 1 | 2020 | 490 | 0.120 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 570 | 0.120 |
Why?
| | Alleles | 1 | 2017 | 845 | 0.120 |
Why?
| | Survival Rate | 4 | 2021 | 1877 | 0.120 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 380 | 0.120 |
Why?
| | Membrane Proteins | 1 | 2021 | 1119 | 0.110 |
Why?
| | Histone Demethylases | 1 | 2014 | 31 | 0.110 |
Why?
| | Immunotherapy | 1 | 2019 | 592 | 0.110 |
Why?
| | Tomography, X-Ray Computed | 1 | 2024 | 2535 | 0.110 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2014 | 42 | 0.110 |
Why?
| | rho GTP-Binding Proteins | 1 | 2014 | 61 | 0.110 |
Why?
| | Transcription, Genetic | 3 | 2017 | 1418 | 0.110 |
Why?
| | Ornithine Decarboxylase Inhibitors | 1 | 2013 | 3 | 0.110 |
Why?
| | Phylogeny | 3 | 2023 | 852 | 0.110 |
Why?
| | Anabolic Agents | 1 | 2013 | 12 | 0.110 |
Why?
| | Models, Theoretical | 1 | 2017 | 547 | 0.110 |
Why?
| | High-Throughput Screening Assays | 1 | 2015 | 138 | 0.110 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2717 | 0.110 |
Why?
| | International Cooperation | 1 | 2014 | 174 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2022 | 821 | 0.110 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2018 | 704 | 0.110 |
Why?
| | Drug Synergism | 1 | 2014 | 371 | 0.110 |
Why?
| | Databases, Protein | 2 | 2014 | 62 | 0.110 |
Why?
| | Organ Sparing Treatments | 1 | 2013 | 32 | 0.110 |
Why?
| | Phenotype | 2 | 2020 | 3076 | 0.110 |
Why?
| | Microsatellite Repeats | 1 | 2014 | 164 | 0.110 |
Why?
| | Infant, Newborn | 2 | 2023 | 5762 | 0.110 |
Why?
| | Epigenomics | 1 | 2014 | 110 | 0.110 |
Why?
| | Drug Combinations | 1 | 2014 | 330 | 0.110 |
Why?
| | Arthritis, Rheumatoid | 1 | 2022 | 1092 | 0.110 |
Why?
| | Models, Molecular | 1 | 2018 | 1492 | 0.110 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2020 | 592 | 0.100 |
Why?
| | Cluster Analysis | 2 | 2016 | 482 | 0.100 |
Why?
| | Models, Statistical | 1 | 2016 | 623 | 0.100 |
Why?
| | Superoxides | 1 | 2013 | 201 | 0.100 |
Why?
| | Brain Neoplasms | 1 | 2021 | 1171 | 0.100 |
Why?
| | Cyclin-Dependent Kinase 4 | 1 | 2012 | 44 | 0.100 |
Why?
| | Community-Institutional Relations | 1 | 2013 | 95 | 0.100 |
Why?
| | Integrins | 2 | 2023 | 94 | 0.100 |
Why?
| | Pregnancy | 2 | 2023 | 6402 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 1 | 2024 | 3408 | 0.100 |
Why?
| | Prostate | 1 | 2013 | 180 | 0.100 |
Why?
| | Biomarkers | 2 | 2021 | 3973 | 0.100 |
Why?
| | Apoptosis | 3 | 2021 | 2503 | 0.100 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 317 | 0.100 |
Why?
| | Software | 2 | 2014 | 608 | 0.100 |
Why?
| | Genome-Wide Association Study | 1 | 2018 | 1333 | 0.090 |
Why?
| | B-Lymphocytes | 2 | 2014 | 815 | 0.090 |
Why?
| | Genome, Insect | 2 | 2009 | 21 | 0.090 |
Why?
| | Male | 11 | 2024 | 63681 | 0.090 |
Why?
| | Alternative Splicing | 1 | 2013 | 218 | 0.090 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 259 | 0.090 |
Why?
| | Saccharomyces cerevisiae | 3 | 2012 | 532 | 0.090 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5440 | 0.090 |
Why?
| | MCF-7 Cells | 2 | 2021 | 116 | 0.090 |
Why?
| | Reactive Oxygen Species | 1 | 2013 | 596 | 0.090 |
Why?
| | Testosterone | 1 | 2013 | 372 | 0.080 |
Why?
| | Hematopoietic Stem Cells | 1 | 2013 | 381 | 0.080 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 827 | 0.080 |
Why?
| | Horns | 1 | 2009 | 1 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2282 | 0.080 |
Why?
| | Pseudogenes | 1 | 2009 | 18 | 0.080 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2012 | 324 | 0.080 |
Why?
| | Expressed Sequence Tags | 1 | 2009 | 41 | 0.080 |
Why?
| | Systems Integration | 1 | 2009 | 38 | 0.080 |
Why?
| | Drug Discovery | 2 | 2022 | 131 | 0.080 |
Why?
| | Coleoptera | 1 | 2009 | 27 | 0.080 |
Why?
| | Inflammation | 1 | 2020 | 2736 | 0.080 |
Why?
| | Models, Genetic | 2 | 2009 | 594 | 0.080 |
Why?
| | Stem Cells | 1 | 2013 | 577 | 0.080 |
Why?
| | Genes, Fungal | 1 | 2009 | 50 | 0.080 |
Why?
| | Genetic Diseases, Inborn | 1 | 2008 | 38 | 0.070 |
Why?
| | Tumor Cells, Cultured | 2 | 2021 | 940 | 0.070 |
Why?
| | Genes, Insect | 1 | 2007 | 21 | 0.070 |
Why?
| | Gene Deletion | 1 | 2009 | 379 | 0.070 |
Why?
| | Zebrafish | 2 | 2022 | 458 | 0.070 |
Why?
| | Combined Modality Therapy | 2 | 2020 | 1206 | 0.070 |
Why?
| | BRCA1 Protein | 2 | 2020 | 65 | 0.070 |
Why?
| | Disease | 1 | 2008 | 95 | 0.070 |
Why?
| | Genetics, Population | 1 | 2008 | 200 | 0.070 |
Why?
| | Genome, Human | 1 | 2009 | 393 | 0.070 |
Why?
| | Neoplasm Staging | 2 | 2024 | 1295 | 0.070 |
Why?
| | Mitochondria | 1 | 2013 | 877 | 0.070 |
Why?
| | Oxidative Stress | 1 | 2013 | 1269 | 0.070 |
Why?
| | Selection, Genetic | 1 | 2008 | 249 | 0.070 |
Why?
| | Prednisone | 2 | 2017 | 233 | 0.060 |
Why?
| | Adult | 4 | 2024 | 35576 | 0.060 |
Why?
| | Chromatin | 2 | 2022 | 479 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2020 | 4897 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2013 | 1928 | 0.060 |
Why?
| | Aged | 5 | 2024 | 22103 | 0.060 |
Why?
| | Cell Line | 3 | 2019 | 2781 | 0.060 |
Why?
| | Base Sequence | 3 | 2017 | 2142 | 0.060 |
Why?
| | Evolution, Molecular | 1 | 2007 | 466 | 0.050 |
Why?
| | Cell Movement | 2 | 2021 | 945 | 0.050 |
Why?
| | Proto-Oncogene Protein c-fli-1 | 1 | 2023 | 24 | 0.050 |
Why?
| | RNA-Binding Protein EWS | 1 | 2023 | 24 | 0.050 |
Why?
| | Internet | 1 | 2008 | 617 | 0.050 |
Why?
| | BCG Vaccine | 1 | 2023 | 24 | 0.050 |
Why?
| | Cells, Cultured | 3 | 2016 | 4083 | 0.050 |
Why?
| | Anti-Bacterial Agents | 1 | 2013 | 1717 | 0.050 |
Why?
| | Protein Binding | 2 | 2020 | 2121 | 0.050 |
Why?
| | Biological Assay | 1 | 2023 | 118 | 0.050 |
Why?
| | Mice, Nude | 2 | 2016 | 683 | 0.050 |
Why?
| | Pituitary Neoplasms | 1 | 2024 | 184 | 0.050 |
Why?
| | Myogenin | 1 | 2022 | 13 | 0.050 |
Why?
| | Proteins | 1 | 2008 | 942 | 0.050 |
Why?
| | MyoD Protein | 1 | 2022 | 32 | 0.050 |
Why?
| | Rhabdomyosarcoma, Embryonal | 1 | 2022 | 20 | 0.050 |
Why?
| | Adjuvants, Immunologic | 1 | 2023 | 221 | 0.050 |
Why?
| | Vagina | 1 | 2023 | 175 | 0.050 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2022 | 87 | 0.050 |
Why?
| | Cell Lineage | 2 | 2013 | 333 | 0.050 |
Why?
| | Contrast Media | 1 | 2024 | 394 | 0.050 |
Why?
| | Chondrogenesis | 1 | 2022 | 82 | 0.050 |
Why?
| | Phenylthiohydantoin | 1 | 2021 | 44 | 0.040 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2022 | 101 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2022 | 2871 | 0.040 |
Why?
| | Wnt Proteins | 1 | 2022 | 127 | 0.040 |
Why?
| | Neural Crest | 1 | 2022 | 114 | 0.040 |
Why?
| | Skull | 1 | 2022 | 129 | 0.040 |
Why?
| | Ephrin-B2 | 1 | 2021 | 50 | 0.040 |
Why?
| | Cartilage | 1 | 2022 | 180 | 0.040 |
Why?
| | Breast | 1 | 2021 | 153 | 0.040 |
Why?
| | Tamoxifen | 1 | 2021 | 200 | 0.040 |
Why?
| | Benzamides | 1 | 2021 | 207 | 0.040 |
Why?
| | Nitriles | 1 | 2021 | 172 | 0.040 |
Why?
| | Melanoma, Experimental | 1 | 2020 | 108 | 0.040 |
Why?
| | beta Catenin | 1 | 2022 | 223 | 0.040 |
Why?
| | Quinolinic Acid | 1 | 2019 | 8 | 0.040 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2020 | 132 | 0.040 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 24 | 0.040 |
Why?
| | Chondrocytes | 1 | 2022 | 203 | 0.040 |
Why?
| | Androgens | 1 | 2021 | 177 | 0.040 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 56 | 0.040 |
Why?
| | Young Adult | 3 | 2024 | 12426 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 169 | 0.040 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 13 | 0.040 |
Why?
| | Enhancer Elements, Genetic | 1 | 2020 | 177 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 1876 | 0.040 |
Why?
| | Inhibitor of Differentiation Proteins | 1 | 2018 | 2 | 0.040 |
Why?
| | Cell Cycle | 1 | 2021 | 592 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 351 | 0.040 |
Why?
| | Enhancer of Zeste Homolog 2 Protein | 1 | 2017 | 41 | 0.040 |
Why?
| | 5-Methylcytosine | 1 | 2017 | 20 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 1 | 2020 | 857 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2020 | 429 | 0.040 |
Why?
| | CpG Islands | 1 | 2017 | 152 | 0.030 |
Why?
| | Middle Aged | 4 | 2024 | 31154 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2023 | 891 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 588 | 0.030 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2017 | 63 | 0.030 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2016 | 39 | 0.030 |
Why?
| | Taxoids | 1 | 2016 | 98 | 0.030 |
Why?
| | Co-Repressor Proteins | 1 | 2016 | 18 | 0.030 |
Why?
| | Chromosome Deletion | 1 | 2016 | 104 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2016 | 157 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 1988 | 0.030 |
Why?
| | Heterografts | 1 | 2016 | 131 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1245 | 0.030 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 253 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 315 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2016 | 170 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2016 | 186 | 0.030 |
Why?
| | rhoC GTP-Binding Protein | 1 | 2014 | 6 | 0.030 |
Why?
| | Exome | 1 | 2016 | 220 | 0.030 |
Why?
| | Protein Domains | 1 | 2016 | 253 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 2016 | 504 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2016 | 2073 | 0.030 |
Why?
| | Sequence Analysis, DNA | 2 | 2008 | 779 | 0.030 |
Why?
| | Zinc Finger E-box Binding Homeobox 2 | 1 | 2014 | 5 | 0.030 |
Why?
| | Urothelium | 1 | 2015 | 37 | 0.030 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2014 | 54 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1274 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2020 | 1056 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1472 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2009 | 2832 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2014 | 257 | 0.030 |
Why?
| | Sequence Analysis, Protein | 1 | 2014 | 28 | 0.030 |
Why?
| | Metabolomics | 1 | 2019 | 652 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 359 | 0.030 |
Why?
| | Eflornithine | 1 | 2013 | 4 | 0.030 |
Why?
| | Ornithine Decarboxylase | 1 | 2013 | 10 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2015 | 285 | 0.030 |
Why?
| | Follistatin | 1 | 2013 | 12 | 0.030 |
Why?
| | Point Mutation | 1 | 2015 | 225 | 0.030 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2014 | 30 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2023 | 2548 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2014 | 213 | 0.030 |
Why?
| | Protein Conformation | 1 | 2016 | 859 | 0.030 |
Why?
| | Blotting, Western | 1 | 2016 | 1205 | 0.030 |
Why?
| | Aminoglycosides | 1 | 2013 | 23 | 0.030 |
Why?
| | Area Under Curve | 1 | 2014 | 304 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2016 | 396 | 0.030 |
Why?
| | beta-Lactams | 1 | 2013 | 28 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1038 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 811 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2017 | 1004 | 0.030 |
Why?
| | Organ Size | 1 | 2013 | 447 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2016 | 487 | 0.030 |
Why?
| | Databases, Factual | 1 | 2018 | 1269 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2017 | 10230 | 0.020 |
Why?
| | Genes, ras | 1 | 2012 | 97 | 0.020 |
Why?
| | Doxycycline | 1 | 2012 | 60 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2013 | 274 | 0.020 |
Why?
| | Cell Cycle Checkpoints | 1 | 2012 | 95 | 0.020 |
Why?
| | Antigens, CD | 1 | 2014 | 489 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2013 | 318 | 0.020 |
Why?
| | Quinolones | 1 | 2013 | 126 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 819 | 0.020 |
Why?
| | Benzimidazoles | 1 | 2012 | 162 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2014 | 406 | 0.020 |
Why?
| | DNA | 1 | 2017 | 1400 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2013 | 480 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2013 | 1304 | 0.020 |
Why?
| | Pupa | 1 | 2009 | 10 | 0.020 |
Why?
| | Gene Library | 1 | 2009 | 116 | 0.020 |
Why?
| | Body Weight | 1 | 2013 | 940 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1086 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2013 | 1698 | 0.020 |
Why?
| | Larva | 1 | 2009 | 214 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2119 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 774 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2012 | 438 | 0.020 |
Why?
| | Adolescent | 2 | 2017 | 20393 | 0.020 |
Why?
| | Synteny | 1 | 2007 | 16 | 0.020 |
Why?
| | Gene Order | 1 | 2007 | 26 | 0.020 |
Why?
| | Genome, Mitochondrial | 1 | 2007 | 26 | 0.020 |
Why?
| | Codon | 1 | 2007 | 86 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2635 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2015 | 2708 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 9765 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2007 | 332 | 0.020 |
Why?
| | Multigene Family | 1 | 2007 | 199 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 6556 | 0.020 |
Why?
| | Immunity | 1 | 2007 | 139 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2024 | 14518 | 0.020 |
Why?
| | DNA Transposable Elements | 1 | 2007 | 118 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2008 | 204 | 0.020 |
Why?
| | RNA, Untranslated | 1 | 2007 | 117 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2017 | 7086 | 0.020 |
Why?
| | Reproduction | 1 | 2007 | 197 | 0.020 |
Why?
| | Drosophila Proteins | 1 | 2007 | 186 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1614 | 0.010 |
Why?
| | Child | 1 | 2023 | 20883 | 0.010 |
Why?
| | RNA | 1 | 2008 | 883 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2008 | 4063 | 0.010 |
Why?
|
|
Costello's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|